Yıldız, F., & Öksüzoğlu, B. (2020). Efficacy and toxicity of everolimus plus exemestane in third and later lines treatment of hormone receptor-positive, HER2-negative metastatic breast cancer. Journal of Surgery and Medicine, 4(6), 443–446. https://doi.org/10.28982/josam.745731